Trending Adaptimmune Therapeutics Plc ADR’s (ADAP) Stock: A Week-by-Week Analysis The stock of Adaptimmune Therapeutics Plc ADR (ADAP) has gone up by 0.79% for the week, with a 5.06% rise in the past month and
Trending Adaptimmune Therapeutics Plc ADR (ADAP) vs. Its Peers: A Comparison Additionally, the 36-month beta value for ADAP is 2.26. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 2